Codes / ICD10CM / H26.33

H26.33 Drug-induced cataract, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Cataract, Bilateral (ICD-10 Code: H26.33)

Summary

Drug-induced cataract, bilateral, refers to clouding of the lens in both eyes caused by medication use. This condition impairs vision by scattering or blocking light, potentially leading to reduced visual acuity or other visual disturbances. The term "bilateral" specifies that the cataract affects both eyes.

Causes

Drug-induced cataracts result from prolonged or high-dose use of medications that affect lens metabolism or structure. Common culprits include corticosteroids, certain antipsychotics, and chemotherapy agents. The exact mechanism varies by drug but often involves oxidative stress or disruption of lens protein synthesis.

Risk Factors

  • Prolonged use of systemic or topical corticosteroids.
  • Use of phenothiazine antipsychotics (e.g., chlorpromazine).
  • Exposure to certain chemotherapy agents (e.g., busulfan).
  • High cumulative doses of implicated medications.
  • Pre-existing lens vulnerability (e.g., age-related changes).

Symptoms

  • Blurred or hazy vision in both eyes.
  • Difficulty with night vision or glare sensitivity in both eyes.
  • Fading or yellowing of colors in both eyes.
  • Double vision in both eyes.
  • Frequent changes in eyeglass prescription for both eyes.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp evaluation, and retinal assessment. Additional tests, such as lens photography or optical coherence tomography, may be used to assess the extent of lens opacity. A detailed medication history is critical to identify potential drug-related causes.

Treatment Options

Treatment depends on the severity of vision impairment. Mild cases may be managed with updated eyeglass or contact lens prescriptions. For significant vision loss, surgical removal of the cloudy lens (cataract extraction) with intraocular lens implantation is the standard intervention. Discontinuing or adjusting the causative medication, if feasible, may slow progression.

Prognosis and Follow-Up

Prognosis is generally good with appropriate treatment, as cataract surgery effectively restores vision in most cases. Regular follow-up with an ophthalmologist is recommended to monitor lens changes and adjust treatment as needed. If the causative drug cannot be discontinued, cataracts may recur or progress, requiring ongoing evaluation.

Complications

Untreated cataracts can lead to severe vision loss, increasing the risk of falls or accidents. Surgical complications, though rare, may include infection, inflammation, or retinal detachment. Long-term use of causative medications may also contribute to other ocular or systemic issues.

Lifestyle & Prevention

  • Avoid or minimize use of medications known to cause cataracts when possible.
  • Use protective eyewear in bright light to reduce glare.
  • Maintain regular eye examinations, especially if taking high-risk medications.
  • Follow prescribed dosages and durations for medications to limit exposure.

When to Seek Professional Help

Seek prompt medical attention if you experience sudden or worsening vision changes, such as increased blurriness, glare sensitivity, or difficulty with daily activities. Early evaluation can prevent progression and guide timely intervention.

Tips for Medical Coders

Document the bilateral nature of the cataract and any associated medication use. Ensure the code H26.33 is used when the condition affects both eyes and is drug-induced. Include details about the causative agent and duration of use in the medical record to support coding accuracy.

Book a walkthrough

H26.33 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.